Regarding the mechanism of action, the CD44+/CD24− phenotype is linked to an increase of the PI3K/Akt/mTOR-signaling pathway in MCF-7 cells, and ERK activation is a key event in EGFR-dependent regulation of CD44+/CD24− population in triple-negative BC cells [59,60]. The gene discussed is MTOR; the disease is breast cancer.